Pimavanserin (Nuplazid)

pimavanserin · ACADIA Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Pimavanserin (Nuplazid), covering 2014-03-26 to 2025-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia [Phase 3]